GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Kimia Farma Tbk (ISX:KAEF) » Definitions » Change In Receivables

PT Kimia Farma Tbk (ISX:KAEF) Change In Receivables : Rp0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is PT Kimia Farma Tbk Change In Receivables?

PT Kimia Farma Tbk's change in receivables for the quarter that ended in Sep. 2024 was Rp0 Mil. It means PT Kimia Farma Tbk's Accounts Receivable stayed the same from Jun. 2024 to Sep. 2024 .

PT Kimia Farma Tbk's change in receivables for the fiscal year that ended in Dec. 2023 was Rp0 Mil. It means PT Kimia Farma Tbk's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

PT Kimia Farma Tbk's Accounts Receivable for the quarter that ended in Sep. 2024 was Rp1,943,583 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. PT Kimia Farma Tbk's Days Sales Outstanding for the three months ended in Sep. 2024 was 66.91.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. PT Kimia Farma Tbk's liquidation value for the three months ended in Sep. 2024 was Rp-8,118,638 Mil.


PT Kimia Farma Tbk Change In Receivables Historical Data

The historical data trend for PT Kimia Farma Tbk's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kimia Farma Tbk Change In Receivables Chart

PT Kimia Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PT Kimia Farma Tbk Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PT Kimia Farma Tbk Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Kimia Farma Tbk  (ISX:KAEF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

PT Kimia Farma Tbk's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1943582.756/2650568.513*91
=66.91

2. In Ben Graham's calculation of liquidation value, PT Kimia Farma Tbk's accounts receivable are only considered to be worth 75% of book value:

PT Kimia Farma Tbk's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=505105.778-11093401.309+0.75 * 1943582.756+0.5 * 2023940.957
=-8,118,638

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Kimia Farma Tbk Change In Receivables Related Terms

Thank you for viewing the detailed overview of PT Kimia Farma Tbk's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kimia Farma Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.

PT Kimia Farma Tbk Headlines

No Headlines